Patent · US Active

Modulators of cystic fibrosis transmembrane conductance regulator

US8314239B2 · kind B2 · utility

96Cited by
1References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2009
Grant dateNov 20, 2012
Priority date
Expiry dateSep 20, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to modulators of cystic fibrosis transmembrane conductance regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating diseases using modulators of CFTR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.